MedCrypt Closes $25M Series B

StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data

Cosmo Pharmaceuticals (SIX Swiss: COSM) found itself this past week in the enviable position of attracting welcome attention from investors and other market watchers after

NETREAPER Offensive Security Toolkit That Wraps 70+ Penetration Testing Tools

A unified offensive security toolkit, NETREAPER, developed by OFFTRACKMEDIA Studios, consolidates over 70 penetration testing tools into a single, user-friendly command-line interface. This innovation eliminates

What Healthcare Can Learn from the NFL

The NFL’s secret weapon for injury prevention is data interoperability, according to Allen Sills, the league’s chief medical officer. The post What Healthcare Can Learn

Shining Light on How Protagonist, Takeda Drug Brings Treatment of a Rare Blood Disease Out of the Dark Ages

Protagonist Therapeutics’ drug rusfertide reduced the need for phlebotomies as a way to treat the rare blood cancer polycythemia vera. Longer-term Phase 3 data for

News and Analysis

Subscribe to newsletter

More Posts

StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data

NETREAPER Offensive Security Toolkit That Wraps 70+ Penetration Testing Tools

What Healthcare Can Learn from the NFL

Shining Light on How Protagonist, Takeda Drug Brings Treatment of a Rare Blood Disease Out of the Dark Ages

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company